U.S. Physical Therapy, Inc.
USPH
$61.96
-$0.43-0.69%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 162.32M | 167.94M | 161.95M | 162.19M | 150.70M |
| Total Other Revenue | 33.96M | 33.05M | 33.11M | 33.16M | 31.24M |
| Total Revenue | 196.28M | 201.00M | 195.06M | 195.35M | 181.94M |
| Cost of Revenue | 157.94M | 156.58M | 152.73M | 147.92M | 145.09M |
| Gross Profit | 38.34M | 44.42M | 42.33M | 47.43M | 36.85M |
| SG&A Expenses | 18.27M | 18.13M | 17.41M | 17.48M | 16.25M |
| Depreciation & Amortization | 5.66M | 4.28M | 5.50M | 5.74M | 5.54M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 181.87M | 178.99M | 175.64M | 171.13M | 166.88M |
| Operating Income | 14.41M | 22.01M | 19.42M | 24.22M | 15.06M |
| Income Before Tax | 10.56M | 14.96M | 22.88M | 22.65M | 17.33M |
| Income Tax Expenses | 2.41M | 5.78M | 5.23M | 4.93M | 3.86M |
| Earnings from Continuing Operations | 8.16M | 9.18M | 17.64M | 17.72M | 13.47M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.12M | -5.02M | -4.50M | -5.33M | -3.57M |
| Net Income | 5.04M | 4.15M | 13.14M | 12.39M | 9.90M |
| EBIT | 14.41M | 22.01M | 19.42M | 24.22M | 15.06M |
| EBITDA | 20.41M | 26.64M | 25.25M | 30.27M | 20.93M |
| EPS Basic | -0.12 | -0.43 | 0.48 | 0.58 | 0.80 |
| Normalized Basic EPS | 0.31 | 0.50 | 0.40 | 0.55 | 0.30 |
| EPS Diluted | -0.12 | -0.43 | 0.48 | 0.58 | 0.80 |
| Normalized Diluted EPS | 0.31 | 0.50 | 0.40 | 0.55 | 0.30 |
| Average Basic Shares Outstanding | 15.17M | 15.17M | 15.20M | 15.20M | 15.13M |
| Average Diluted Shares Outstanding | 15.17M | 15.17M | 15.20M | 15.20M | 15.13M |
| Dividend Per Share | 0.46 | 0.45 | 0.45 | 0.45 | 0.45 |
| Payout Ratio | -- | 164.75% | 52.08% | 110.37% | -- |